3 underperforming FTSE 100 shares to buy today

These three FTSE 100 shares are recovering, but still lag the market. Here’s why I’d buy them while there’s still time.

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

When investing, your capital is at risk. The value of your investments can go down as well as up and you may get back less than you put in.

Read More

The content of this article is provided for information purposes only and is not intended to be, nor does it constitute, any form of personal advice. Investments in a currency other than sterling are exposed to currency exchange risk. Currency exchange rates are constantly changing, which may affect the value of the investment in sterling terms. You could lose money in sterling even if the stock price rises in the currency of origin. Stocks listed on overseas exchanges may be subject to additional dealing and exchange rate charges, and may have other tax implications, and may not provide the same, or any, regulatory protection as in the UK.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

Most FTSE 100 shares have been climbing in 2021. And there are some of those I’d still buy today. But what about the shares that have lagged the index this year?

They include Unilever (LSE: ULVR). Investors abandoned what they saw as risky shares last year and flocked to safer stocks like Unilever. As a result, the share price gained. But since the general stock market recovery kicked off in November, Unilever shares have fallen back.

From a high point last year, we’re looking at a 12% drop. That’s better than how things were looking in February though. At the end of that month, Unilever had lost almost 25% from its peak. I reckon it was a buy then, and I’d have had some myself had I not seen even better bargains.

Since a mini-recovery of the past few months, the shares are pretty much flat in 2021, compared to a 10% gain for the FTSE 100.

I see a risk that investors will continue to shun last year’s safe stocks, and Unilever could suffer a weak 2021. But I still see it a long-term buy, and it’s on my shortlist.

Top FTSE 100 dividend

Utilities stocks have performed poorly in 2021, though they’re starting to come back. I’m looking at National Grid (LSE: NG) right now, which fell quite hard in the first three months of the year. It’s been recovering, but the bigger picture shows weakness.

The National Grid share price is still down 10% since the stock market crash kicked off in mid-February last year. So it’s been lagging the FTSE 100 recovery, but does that make it a bargain?

National Grid has reported falling underlying earnings per share for a couple of years. But that should hopefully pick up again now, and I don’t see any long-term threat to the dividend. The 2021 dividend represents a 5.3% yield on the current National Grid share price — one of the FTSE 100’s best.

In these days of super-low interest rates, I see that as especially attractive. But it does suggest to me that the market values National Grid too lowly. Is that related to the hydrocarbon energy crisis? Though National Grid should still do fine however energy is generated, I do see some threat there.

We’re heading for an energy transition, and that could affect the entire delivery chain. Still, National Grid remains on my dividend buy list.

Falling pharma

My third choice is GlaxoSmithKline (LSE: GSK). And it does seem strange for a pharmaceuticals company to be underperforming in the pandemic. Maybe it’s because its name isn’t associated with a Covid vaccine, unlike Footsie competitor AstraZeneca?

Whatever the reason, Glaxo shares are down 14% since the crash started. And though they’ve picked up in the past few months, they still lag the FTSE 100 in 2021.

But is GlaxoSmithKline a buy now? Firstly, a lot of investors have approached the pharma business very differently in the past couple of years. That’s not surprising, with the prospect of big short-term gains from coronavirus research hovering in front of us. But I have to remind myself that pharmaceuticals is a long-term business.

And with a long-term horizon, I have Glaxo down as one to buy on the dips.

Should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice.

Alan Oscroft has no position in any of the shares mentioned. The Motley Fool UK has recommended GlaxoSmithKline, National Grid, and Unilever. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Investing Articles

Are these the best stocks to buy on the FTSE right now?

With the UK stock market on the way to hitting new highs, this Fool is considering which are the best…

Read more »

Petrochemical engineer working at night with digital tablet inside oil and gas refinery plant
Investing Articles

Can the Centrica dividend keep on growing?

Christopher Ruane considers some positive factors that might see continued growth in the Centrica dividend -- as well as some…

Read more »

Smiling family of four enjoying breakfast at sunrise while camping
Investing Articles

How I’d turn my £12,000 of savings into passive income of £1,275 a month

This Fool is considering a strategy that he believes can help him achieve a stable passive income stream with a…

Read more »

Person holding magnifying glass over important document, reading the small print
Investing Articles

2 top FTSE 250 investment trusts trading at attractive discounts!

This pair of discounted FTSE 250 trusts appear to be on sale right now. Here's why I'd scoop up their…

Read more »

Smiling young man sitting in cafe and checking messages, with his laptop in front of him.
Investing Articles

3 things that could push the Lloyds share price to 60p and beyond

The Lloyds share price has broken through 50p. Next step 60p? And then what? Here are some thoughts on what…

Read more »

Young female business analyst looking at a graph chart while working from home
Investing Articles

£1,000 in Rolls-Royce shares a year ago would be worth this much now

Rolls-Royce shares have posted one of the best stock market gains of the past 12 months. But what might the…

Read more »

Investing Articles

Are HSBC shares a FTSE bargain? Here’s what the charts say!

There are plenty of dirt-cheap FTSE 100 banking stocks for investors to choose from today. Our writer Royston Wild believes…

Read more »

Three signposts pointing in different directions, with 'Buy' 'Sell' and 'Hold' on
Investing Articles

Just released: Share Advisor’s latest ‘Hold’ recommendation [PREMIUM PICKS]

In our Share Advisor newsletter service, we provide buy, sell, and hold guidance for our universe of recommendations.

Read more »